Shelter Pharma Limited (BOM:543963)
43.00
-1.15 (-2.60%)
At close: Sep 18, 2025
Shelter Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2020 |
Cash & Equivalents | 34.2 | 50.4 | 4.29 | 1 | 3.71 | Upgrade |
Cash & Short-Term Investments | 34.2 | 50.4 | 4.29 | 1 | 3.71 | Upgrade |
Cash Growth | -32.14% | 1076.13% | 328.07% | -72.98% | 166.93% | Upgrade |
Accounts Receivable | 94.75 | 88.5 | 81.95 | 16.06 | 7.6 | Upgrade |
Other Receivables | - | - | - | 0.84 | 0.66 | Upgrade |
Receivables | 94.75 | 88.5 | 81.95 | 16.89 | 8.26 | Upgrade |
Inventory | 128.95 | 99.29 | 79.65 | 56.74 | 40.15 | Upgrade |
Prepaid Expenses | - | 0 | 0.01 | 0.01 | - | Upgrade |
Other Current Assets | 74.89 | 59 | 21.27 | 23.68 | 26.67 | Upgrade |
Total Current Assets | 332.79 | 297.19 | 187.16 | 98.32 | 78.78 | Upgrade |
Property, Plant & Equipment | 59.51 | 35.71 | 18.45 | 20.05 | 15.69 | Upgrade |
Long-Term Investments | 0.01 | 0.01 | 0.01 | 0.01 | - | Upgrade |
Other Intangible Assets | 0.1 | 0.09 | - | - | - | Upgrade |
Long-Term Deferred Tax Assets | 0.32 | 0.36 | - | - | - | Upgrade |
Other Long-Term Assets | 90.63 | 45.81 | 8.87 | 10.02 | 7.55 | Upgrade |
Total Assets | 483.36 | 379.15 | 214.48 | 128.39 | 102.02 | Upgrade |
Accounts Payable | 12.51 | 7.14 | 4.68 | 3.23 | 3.12 | Upgrade |
Accrued Expenses | 1.75 | 1.25 | 0.73 | 0.05 | 0.14 | Upgrade |
Short-Term Debt | 1.13 | 0.04 | 13.04 | 0.38 | 0.05 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | 0.29 | - | Upgrade |
Current Income Taxes Payable | 30.02 | 5.66 | 17.79 | 6.5 | 0.02 | Upgrade |
Current Unearned Revenue | - | - | 25 | - | - | Upgrade |
Other Current Liabilities | 0.88 | 0.66 | 1.24 | 26.63 | 25.24 | Upgrade |
Total Current Liabilities | 46.29 | 14.75 | 62.48 | 37.07 | 28.56 | Upgrade |
Long-Term Debt | 9.32 | 5.73 | 4.8 | 0.65 | - | Upgrade |
Long-Term Deferred Tax Liabilities | - | - | 1.23 | 1.01 | 1 | Upgrade |
Other Long-Term Liabilities | -0 | -0 | -0 | -0 | -0 | Upgrade |
Total Liabilities | 56.15 | 20.99 | 69 | 39.11 | 30.44 | Upgrade |
Common Stock | 115.6 | 115.6 | 77.44 | 4.84 | 4.84 | Upgrade |
Additional Paid-In Capital | 122.11 | 122.11 | 39.96 | 39.96 | 39.96 | Upgrade |
Retained Earnings | 180.08 | 111.03 | 18.67 | 35.07 | 17.36 | Upgrade |
Comprehensive Income & Other | 9.42 | 9.42 | 9.42 | 9.42 | 9.42 | Upgrade |
Shareholders' Equity | 427.21 | 358.16 | 145.49 | 89.29 | 71.58 | Upgrade |
Total Liabilities & Equity | 483.36 | 379.15 | 214.48 | 128.39 | 102.02 | Upgrade |
Total Debt | 10.44 | 5.77 | 17.84 | 1.31 | 0.05 | Upgrade |
Net Cash (Debt) | 23.76 | 44.62 | -13.56 | -0.31 | 3.66 | Upgrade |
Net Cash Growth | -46.76% | - | - | - | - | Upgrade |
Net Cash Per Share | 2.06 | 3.86 | -1.75 | -0.04 | 0.49 | Upgrade |
Filing Date Shares Outstanding | 11.56 | 11.56 | 11.56 | 7.74 | 7.74 | Upgrade |
Total Common Shares Outstanding | 11.56 | 11.56 | 7.74 | 7.74 | 7.74 | Upgrade |
Working Capital | 286.5 | 282.44 | 124.68 | 61.25 | 50.22 | Upgrade |
Book Value Per Share | 36.96 | 30.98 | 18.79 | 11.53 | 9.24 | Upgrade |
Tangible Book Value | 427.11 | 358.07 | 145.49 | 89.29 | 71.58 | Upgrade |
Tangible Book Value Per Share | 36.95 | 30.98 | 18.79 | 11.53 | 9.24 | Upgrade |
Buildings | - | 40.19 | 30.69 | 25.14 | 24.65 | Upgrade |
Machinery | - | 10.58 | 6.56 | 6.52 | 6.5 | Upgrade |
Construction In Progress | - | 6.18 | - | 5.55 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.